We anticipate receiving 24 month interim data in late 2009
Our lead development product, Iluvien™, is in fully-enrolled Phase III clinical trials for the treatment of Diabetic Macular Edema (DME). We anticipate receiving 24 month interim data in late 2009 which will form the basis for our anticipated NDA filing with FDA in early 2010. Iluvien utilizes Medidur™, our third generation miniaturized, sustained-release drug delivery technology.
Siam Kitty say she ate the rat in charge of web pumpings. Now, PSDV saves money instead of paying extra salary for web-rat.
Now, Siam Kitty chasing the PR rats around. They have become a little fatter and lazier. Too many kibbles for them and no exercising. Siam Kitty gets them moving again, because they don't care about Micky Mack email wishings. They do worry about big Kitty, though.
Did Mr. Roomy say he hear PSDV drug might get approval? Hmm.............Siam Kitty love kendolldownthere. He nice man. He scare Isaac away and Timmy Chicken bird. Now maybe he buying?